EducationWorld

Covid 19 vaccine for children: Is India way behind?

World Map
Shreyosi Chakraborty

With the Covid-19 graph indicates a downward trend, several Indian state governments are already thinking of re-opening the schools. While doctors and researchers predicted the third wave of Coronavirus disease to affect children below 18, parents are concerned about their wards’ health and worried about sending them to schools.

Meanwhile, All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria has recently said that getting the vaccines available for children would be a “milestone achievement”.

If the Zydus Cadila vaccine gets approval it would be an option,” Dr Guleria told news agency PTI. The doctor had previously also said that data from phase 2 and 3 trials of Bharat Biotech’s Covaxin on the 2-18 age group is likely to be available by September following which the vaccine might receive approval from the Drugs Controller General of India (DCGI).

If the Pfizer vaccine is approved before that, it could also be an option, Dr Guleria further reiterated. “Availability of Covid-19 vaccine for children would pave the way for the reopening of schools and outdoor activities. Schools have to be reopened as there has been a major loss in studies in the last 18 months due to the pandemic,” he stressed.

Dr Guleria also cautioned that though children have mild Covid-19 infections and some are even asymptomatic, they can be carriers of the viral disease.

Let us look at the countries that have already vaccinated children below 18 years of age or are considering doing so. As far as the European Commission is considered, they have authorized Pfizer and BioNTech’s Covid-19 vaccine to be used in children as young as 12 but left decisions on when to roll out the shots up to member states. 

NORTH and SOUTH AMERICA

  • Brazil: Approved use of Pfizer’s vaccine for children over 12 on June 11.
  • Chile: The country approved use of Pfizer’s vaccine for 12 to 16-year-olds. 
  • USA: Began inoculating young adolescents in mid-May.
  • Canada: Approved use of Pfizer’s vaccine for use in children aged 12-15 in early May

EUROPE (EU COUNTRIES)

EUROPE (NON-EU COUNTRIES)

MIDDLE EAST

ASIA-PACIFIC

Source: Reuters

Also Read: Pfizer likely to be available in India for adults, children